Varied Properties of Hepatitis-Delta Virus-like Particles Produced by Baculovirus-transduced Mammalian Cells
Integration of life sciences & engineering
Integration of Life Sciences & Engineering - Poster (T5-P)
Keywords: baculovirus; hepatitis delta virus; virus-like particles; mammalian cells
Hepatitis delta virus-like particles (HDV VLP) may be a promising vaccine candidate against hepatitis delta virus, which causes severe acute liver inflammation or chronic liver diseases. Currently there is no effective vaccine or diagnostic reagent for HDV due to the lack of a proper method to efficiently produce HDV VLP. To mass produce HDV VLP, we constructed recombinant baculoviruses Bac-GD expressing large-hepatitis delta antigen (L-HDAg) and Bac-GB expressing hepatitis B surface antigen (HBsAg). In this study, we demonstrated that co-transduction of mammalian cells led to co-expression of both proteins, as well as secretion of HDV VLP. However, we found that the ratios of virus dosages led to changes in VLP properties. A high dosage ratio of Bac-GD to Bac-GB led to higher L-HDAg expression relative to HBsAg, which in turn resulted in the incorporation of more L-HDAg into VLP, larger particle size, and larger density. A model correlating the VLP properties and the relative baculovirus dosage is proposed.
Presented Wednesday 19, 13:30 to 15:00, in session Integration of Life Sciences & Engineering - Poster (T5-P).